Key Developments: CVS Caremark Corp (CVS.N)

CVS.N on New York Stock Exchange

73.91USD
16 Apr 2014
Price Change (% chg)

$0.47 (+0.64%)
Prev Close
$73.44
Open
$74.12
Day's High
$74.22
Day's Low
$73.51
Volume
1,310,616
Avg. Vol
1,689,884
52-wk High
$76.36
52-wk Low
$55.67

Search Stocks

Latest Key Developments (Source: Significant Developments)

Cvs Caremark Corp Announces Quarterly Dividend
Wednesday, 25 Sep 2013 03:10pm EDT 

Cvs Caremark Corp announced that its board of directors has approved a quarterly dividend of $0.225 per share on the corporation's common stock. The dividend is payable on November 1, 2013, to holders of record on October 21, 2013.  Full Article

Cvs Caremark Corp Narrows FY 2013 EPS Guidance To A Range Below Analysts' Estimates; Issues Q3 2013 EPS Guidance In Line With Analysts' Estimates
Tuesday, 6 Aug 2013 07:00am EDT 

Cvs Caremark Corp narrowed its fiscal 2013 adjusted EPS range to $3.90 to $3.96 and GAAP diluted EPS from continuing operations range to $3.65 to $3.71. For the third quarter of 2013, it expects adjusted EPS guidance of $1.00 to $1.03 and GAAP diluted EPS from continuing operations guidance of $0.94 to $0.97. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.98 for fiscal 2013 and EPS of $0.97 for the third quarter of 2013.  Full Article

Cvs Caremark Corp Announces Quarterly Dividend
Wednesday, 10 Jul 2013 01:05pm EDT 

Cvs Caremark Corp announced that its Board of Directors has approved a quarterly dividend of $0.225 per share on the Common Stock of the Corporation, payable August 2, 2013, to holders of record on July 22, 2013.  Full Article

Cvs Caremark Corp Reaffirms FY 2013 EPS Guidance-Conference Call
Tuesday, 21 May 2013 08:45am EDT 

Cvs Caremark Corp announced that for fiscal 2013, it expects deliver adjusted earnings per share (EPS) from continuing operations in the range of $3.89 to $4.00 a share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.98 for fiscal 2013.  Full Article

Cvs Caremark Corp Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates; Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates
Wednesday, 1 May 2013 07:00am EDT 

Cvs Caremark Corp announced that for fiscal 2013, it expects to deliver adjusted EPS of $3.89 to $4.00 and GAAP diluted earnings per share from continuing operations of $3.64 to $3.75 per share in fiscal 2013. For second quarter of 2013, it expects adjusted EPS guidance of $0.94 to $0.97 and GAAP diluted EPS from continuing operations guidance of $0.88 to $0.91. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.97 for fiscal 2013; EPS of $0.94 for second quarter of 2013.  Full Article

Cvs Caremark Corp Gets Contract To Serve 1.1 Million CareFirst Members-Reuters
Tuesday, 30 Apr 2013 04:27pm EDT 

Reuters reported that Cvs Caremark Corp is set to provide pharmacy benefit and other services for 1.1 million CareFirst BlueCross BlueShield members starting next year. The three-year contract is the latest win for CVS Caremark, which has been gaining ground with its combined approach of running retail drugstores and a pharmacy benefits management business. CareFirst announced the contract, which begins on January 1, 2014. It said the contract covers its commercial and Medicare Part D members.  Full Article

Cvs Caremark Corp Announces Quarterly Dividend
Wednesday, 6 Mar 2013 01:26pm EST 

Cvs Caremark Corp announced that its board of directors has approved a quarterly dividend of $0.225 (22.5 cents) per share on the corporation's common stock. The dividend is payable on May 3, 2013, to holders of record on April 23, 2013.  Full Article

Cvs Caremark Corp Buys Drogaria Onofre-Reuters
Wednesday, 6 Feb 2013 09:06pm EST 

Reuters reported that Cvs Caremark Corp said it has bought Drogaria Onofre, Brazil's drugstore chain.  Full Article

Cvs Caremark Corp Raises FY 2013 EPS Guidance
Wednesday, 6 Feb 2013 07:00am EST 

Cvs Caremark Corp raised its earnings guidance for fiscal 2013 to reflect the anticipated two cents per share of EPS accretion related to the debt tender and refinancing that was executed during the fourth quarter of last year. The Company currently expects to deliver Adjusted EPS of $3.86 to $4.00 and GAAP diluted earnings per share from continuing operations of $3.61 to $3.75 per share in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.94 for fiscal 2013.  Full Article

Cvs Caremark Corp's MinuteClinic And Barnabas Health Enter Into Clinical Collaboration in Monmouth and Ocean Counties
Thursday, 24 Jan 2013 08:30am EST 

MinuteClinic, the retail health care division of Cvs Caremark Corp and Barnabas Health in New Jersey announced that they have signed a clinical collaboration to enhance access to high quality, affordable health care services in Monmouth and Ocean counties. Under the agreement, Barnabas Health physicians will serve as medical directors for three MinuteClinic walk-in medical clinics open seven days a week inside select CVS/pharmacy stores in Jackson, Manalapan and Marlboro, New Jersey. In addition, MinuteClinic and Barnabas Health will collaborate on patient education and disease management initiatives and will inform patients of the services each provide. Barnabas Health will accept patients who need a level of care that is not provided among MinuteClinic services. Signage at MinuteClinic locations will inform patients that each site has an affiliation with Barnabas Health.  Full Article

Photo

CVS to pay $20 million to settle SEC fraud charges

- CVS Caremark Corp, the second largest U.S. drugstore chain, will pay $20 million to settle U.S. Securities and Exchange Commission charges that it defrauded investors in 2009 during a debt offering and by accounting improperly for an acquisition.

Search Stocks